U.S. market Open. Closes in 3 hours 2 minutes

MRNA | Moderna, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for MRNA we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is very good and Health is strong.

Valuation (47%)

Company Industry
P/E Ratio (TTM) -3.47 -23.05
PEG Ratio (TTM) -1.88 15.47
P/S Ratio (TTM) 4.04 49.46
P/B Ratio (TTM) 1.74 18.87
P/FCF Ratio (TTM) -5.13 -3.27
Price to 5YR AVG Earnings Ratio 7.45 -3.55
Price to 5YR AVG FCF Ratio 6.56 -9.37

Profitability (25%)

Company Industry
ROA (TTM) -37.42% -5.14%
ROE (TTM) -45.27% 16.69%
Net Profit Margin (TTM) -116.13% -1,583.93%
ROIC 5YR AVG 44.32% 15.15%

Growth (75%)

4QTR AVG 3YR AVG 5YR AVG
EPS -176.44% 561.92% 299.53%
Revenue 109.04% 2,257.36% 1,343.15%
Net Income -176.85% 551.46% 293.31%
Cash Flow -55.95% 358.29% 169.77%

Health (63%)

Company Industry
Current Ratio (TTM) 4.09 6.13
Quick Ratio (TTM) 3.92 5.85
D/E Ratio (TTM) 0.11 -15.81
Interest Coverage (TTM) -165.54 -1.57
Piotroski F-Score 3 5
Altman Z-Score 4.06 14.12
LTL to 5YR AVG FCF 0.39 0.17
Shares Outstanding Growth 5YR AVG 64.70% 123.44%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙